Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment (vol 62, pg 65, 2022)M. J. A. Lainez,J. Schoenen,C. StroudHEADACHE(2022)引用 5|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要